Compounds > 9-hydroxy-10,12-octadecadienoic acid

9-hydroxy-10,12-octadecadienoic acid and troglitazone

9-hydroxy-10,12-octadecadienoic acid has been researched along with troglitazone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aaltonen, LA; de la Chapelle, A; Eng, C; Kum, JB; Mueller, E; Sarraf, P; Smith, WM; Spiegelman, BM; Wright, HM1
Chen, NG; Feldman, D; Malloy, PJ; Reaven, GM; Sarabia, SF; Zhao, XY1
Aljada, A; Dandona, P; Friedman, J; Garg, R; Ghanim, H; Mohanty, P1
Aljada, A; Assian, E; Dandona, P; Garg, R; Ghanim, H; Hamouda, W; Mohanty, P1

Trials

1 trial(s) available for 9-hydroxy-10,12-octadecadienoic acid and troglitazone

ArticleYear
Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action?
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:7

    Topics: Adult; Anti-Inflammatory Agents; Blood Glucose; C-Reactive Protein; Chemokine CCL2; Cholesterol; Chromans; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Humans; I-kappa B Proteins; Insulin; Intercellular Adhesion Molecule-1; Leukocytes, Mononuclear; Linoleic Acid; Linoleic Acids; Linoleic Acids, Conjugated; Male; Middle Aged; NADPH Oxidases; Neutrophils; NF-kappa B; Obesity; Phenylalanine; Phosphoproteins; Plasminogen Activator Inhibitor 1; Reactive Oxygen Species; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone; Tyrosine

2001

Other Studies

3 other study(ies) available for 9-hydroxy-10,12-octadecadienoic acid and troglitazone

ArticleYear
Loss-of-function mutations in PPAR gamma associated with human colon cancer.
    Molecular cell, 1999, Volume: 3, Issue:6

    Topics: Amino Acid Substitution; Binding Sites; Chromans; Colorectal Neoplasms; Dimerization; DNA-Binding Proteins; Exons; Genes, Tumor Suppressor; Humans; Hydroxyeicosatetraenoic Acids; Ligands; Linoleic Acids; Linoleic Acids, Conjugated; Mutation; Prostaglandin D2; Protein Binding; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Response Elements; Retinoid X Receptors; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Troglitazone

1999
PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression.
    Biochemical and biophysical research communications, 1999, Oct-05, Volume: 263, Issue:3

    Topics: Antioxidants; Cell Adhesion; Cell Line, Transformed; Chromans; DNA-Binding Proteins; Endothelium, Vascular; Gene Expression Regulation; Humans; Intercellular Adhesion Molecule-1; Linoleic Acids; Linoleic Acids, Conjugated; Lipopolysaccharides; Lipoproteins, LDL; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection; Troglitazone; Tumor Necrosis Factor-alpha; Umbilical Veins

1999
Troglitazone reduces the expression of PPARgamma while stimulating that of PPARalpha in mononuclear cells in obese subjects.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:7

    Topics: Adult; Antioxidants; Blood Glucose; Blotting, Western; Chromans; Female; Humans; Insulin; Leukocytes, Mononuclear; Linoleic Acids; Linoleic Acids, Conjugated; Lipids; Male; Middle Aged; Obesity; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone

2001